Antitumor Activity of miR-34a in Peritoneal Mesothelioma Relies on C-Met and AXL Inhibition: Persistent Activation of ERK and AKT Signaling as a Possible Cytoprotective Mechanism

Journal of Hematology and Oncology - United Kingdom
doi 10.1186/s13045-016-0387-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

P2.06-42 AXL, C-Met and VEGFR2 Tyrosine Kinase Receptors as Therapeutic Targets in Malignant Pleural Mesothelioma.

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Mechanism Research of miR‐34a Regulates Axl in Non‐small‐cell Lung Cancer With Gefitinib‐acquired Resistance

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2019English

Hsp90 Inhibition Transiently Activates SRC Kinase and Promotes SRC-Dependent Akt and Erk Activation

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2006English

Antitumor Activity of Gambogic Acid on NCI-H1993 Xenografts via MET Signaling Pathway Downregulation

Oncology Letters
Cancer ResearchOncology
2015English

mTOR Activation by PI3K/Akt and ERK Signaling in Short ELF-EMF Exposed Human Keratinocytes

PLoS ONE
Multidisciplinary
2015English

RON and C-Met Facilitate Metastasis Through the ERK Signaling Pathway in Prostate Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
2017English

Neuronal Orphan G-Protein Coupled Receptor Proteins Mediate Plasmalogens-Induced Activation of ERK and Akt Signaling

PLoS ONE
Multidisciplinary
2016English

Cell Type-Specific Activation of AKT and ERK Signaling Pathways by Small Negatively-Charged Magnetic Nanoparticles

Scientific Reports
Multidisciplinary
2012English

MicroRNA-34a (miR-34a)

Science-Business eXchange
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy